Information about Global Cancer Strategies
My details
*
*
*

Global Cancer Strategies (SRL)

BE 0783.644.885

Rue des Chevaliers 6/7, 1050 Ixelles

Company information

Status
Active

Enterprise number

BE0783.644.885

VAT liability
Yes
Established
21-03-2022
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Global Cancer Strategies

2024 2023 2022
Profit/Loss € -18,153 -134 % € 53,707 828 % € 5,786
Equity € 42,339 -30 % € 60,492 791 % € 6,786
Gross margin € -17,247 -125 % € 68,804 706 % € 8,536

Publications from Global Cancer Strategies

Date Publication
23-03-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Global Cancer Strategies?
The VAT number of Global Cancer Strategies is BE 0783.644.885.
Wat is the PEPPOL ID of Global Cancer Strategies?
The PEPPOL ID of Global Cancer Strategies is 0208:0783644885. Log in or start a free trial to see the full overview.
When was Global Cancer Strategies founded?
Global Cancer Strategies was founded on 21-03-2022.
What is the address of Global Cancer Strategies?
The current registered office of Global Cancer Strategies is located at Rue des Chevaliers 6/7, 1050 Ixelles.
When was the last time Global Cancer Strategies filed their annual financial statements?
The most recent financial statements of Global Cancer Strategies were filed on 28-04-2025.
How many employees does Global Cancer Strategies have?
There are currently no employees working at Global Cancer Strategies or no workforce information is available.
What is the annual turnover of Global Cancer Strategies?
At the time of its most recent financial statements, Global Cancer Strategies did not publish any turnover figures. Global Cancer Strategies reported a gross margin of -€17,246.93.

Sources